| 0 | 💬 0 |
Development of a structurally distinct TopBP1 inhibitor that enhances PARP blockade and reverses osimertinib resistance.
(science.org)
|
Science Advances 2026-08-05 | #cancer #amr #inhibitor #nsclc #protein-interactions |